Anyone arriving in Orlando, Florida expecting the Disney enchantment of Cinderella’s Castle may have wondered if they were in the right place. ASH 2025 showed up with a clenched fist and never loosened it. Under the rallying call of ‘Fight 4 Hematology’, the meeting stepped forward with purpose, urging the community to ‘fight for science, fight for research, fight for haematology and fight for patients’.
That spirit spoke directly to the week’s defining theme: boldness. Bold science pushed the conversation towards outcomes that once belonged in fairytales. Bold exhibition spaces pulled delegates into the mechanics and meaning of breakthrough therapies. And bold advocacy championed inclusion, diversity, funding and access at a time when all four are under pressure. This was Disney territory, but not Disney thinking. Activism, not escapism.
That’s not to say the science didn’t feel quietly magical. Across the programme, advances such as CAR-T therapies and bispecific antibodies shimmered, nudging hard-to-treat cancers like multiple myeloma and aggressive lymphomas closer to the realistic prospect of cure. And where cures remain out of reach, improvements in quality of life and extensions in survival are delivering meaningful gains for patients.
The magic here was grounded in data, discipline and years of hard-won progress that was finally paying off. We may not have the keys to Cinderella’s Castle yet, but haematology has reached the ceremonial steps and is ready to climb them. Here are the highlights.
Read the article in full here.